Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
E. De Vecchi, L. Nicola, E. Zucchetti & L. Drago. (2006)
In Vitro Induction of Resistance by Tissue Concentrations of Azithromycin, Clarithromycin, Cefixime and Amoxicillin/Clavulanate in Clinical Isolates of Streptococcus pyogenes
. Journal of Chemotherapy 18:4, pages 379-388.
Read now
Read now
Mark H Gotfried. (2003) Clarithromycin (Biaxin®) extended-release tablet: a therapeutic review. Expert Review of Anti-infective Therapy 1:1, pages 9-20.
Read now
Read now
Joseph M Blondeau. (2002) The evolution and role of macrolides in infectious diseases. Expert Opinion on Pharmacotherapy 3:8, pages 1131-1151.
Read now
Read now
A. Novelli, S. Fallani, M.I. Cassetta, S. Arrigucci & T. Mazzei. (2002)
In Vivo Pharmacodynamic Evaluation of Clarithromycin in Comparison to Erythromycin. Journal of Chemotherapy 14:6, pages 584-590.
Read now
Read now
Articles from other publishers (18)
Bingyun Lu, Jiamin Wang, Jing Li, Le Liu & Ye Chen. (2019)
Half‐dose clarithromycin‐containing bismuth quadruple therapy is effective and economical in treating
Helicobacter
pylori infection: A single‐center, open‐label, randomized trial
. Helicobacter 24:2, pages e12566.
Crossref
Crossref
Kazuhiro Morimoto. (2013) Designs of Optimized Microbial Therapy Systems of Respiratory Infections呼吸器感染症の抗菌薬を用いた最適治療法の構築. YAKUGAKU ZASSHI 133:1, pages 81-92.
Crossref
Crossref
Kohei TogamiSumio ChonoKazuhiro Morimoto. (2012) Aerosol-Based Efficient Delivery of Clarithromycin, a Macrolide Antimicrobial Agent, to Lung Epithelial Lining Fluid and Alveolar Macrophages for Treatment of Respiratory Infections. Journal of Aerosol Medicine and Pulmonary Drug Delivery 25:2, pages 110-115.
Crossref
Crossref
Ayman M. Noreddin, Walid F. El-Khatib, Jason Aolie, Ahmed H. Salem & George G. Zhanel. (2009) Pharmacodynamic target attainment potential of azithromycin, clarithromycin, and telithromycin in serum and epithelial lining fluid of community-acquired pneumonia patients with penicillin-susceptible, intermediate, and resistant Streptococcus pneumoniae. International Journal of Infectious Diseases 13:4, pages 483-487.
Crossref
Crossref
Joseph M Blondeau. (2006) Update on the use of the macrolides for community-acquired respiratory tract infections. Therapy 3:5, pages 619-650.
Crossref
Crossref
Arantxa Isla, Andr??s Canut, Alicia R Gasc??n, Alicia Labora, Bruno Ardanza-Trevijano, Maria ??ngel??s Solin??s & Jose Luis Pedraz. (2005) Pharmacokinetic/Pharmacodynamic Evaluation of Antimicrobial Treatments of Orofacial Odontogenic Infections. Clinical Pharmacokinetics 44:3, pages 305-316.
Crossref
Crossref
Margaret Trexler Hessen & Donald Kaye. (2004) Principles of use of antibacterial agents. Infectious Disease Clinics of North America 18:3, pages 435-450.
Crossref
Crossref
Antonio Anzueto & Sandra Norris. (2004) Clarithromycin in 2003: sustained efficacy and safety in an era of rising antibiotic resistance. International Journal of Antimicrobial Agents 24:1, pages 1-17.
Crossref
Crossref
Candace Smith. (2016) Pharmacokinetic/Pharmacodynamic Considerations in Community-Acquired Lower Respiratory Tract Infections. Journal of Pharmacy Practice 16:5, pages 313-323.
Crossref
Crossref
Dana Maglio, David P Nicolau & Charles H Nightingale. (2003) Impact of pharmacodynamics on dosing of macrolides, azalides, and ketolides. Infectious Disease Clinics of North America 17:3, pages 563-577.
Crossref
Crossref
Malcolm J. M. Darkes & Caroline M. Perry. (2012) Clarithromycin Extended-Release Tablet. American Journal of Respiratory Medicine 2:2, pages 175-201.
Crossref
Crossref
Yoshiro Kohno. 2003. Macrolide Antibiotics. Macrolide Antibiotics
327
361
.
Pamela R. Tessier, Myo-Kyoung Kim, Wen Zhou, Dawei Xuan, Chonghua Li, Min Ye, Charles H. Nightingale & David P. Nicolau. (2002) Pharmacodynamic Assessment of Clarithromycin in a Murine Model of Pneumococcal Pneumonia. Antimicrobial Agents and Chemotherapy 46:5, pages 1425-1434.
Crossref
Crossref
Joseph P. LynchIIIIII & Fernando J. Martinez. (2002) Clinical Relevance of Macrolide-Resistant Streptococcus pneumoniae for Community-Acquired Pneumonia. Clinical Infectious Diseases 34:Supplement_1, pages S27-S46.
Crossref
Crossref
Herbert Kirst. 2001. Kirk-Othmer Encyclopedia of Chemical Technology. Kirk-Othmer Encyclopedia of Chemical Technology.
F Van Bambeke & P.M Tulkens. (2001) Macrolides: pharmacokinetics and pharmacodynamics. International Journal of Antimicrobial Agents 18, pages 17-23.
Crossref
Crossref
Jasjit Singh, Bill Burr, Del Stringham & Antonio Arrieta. (2001) Commonly Used Antibacterial and Antifungal Agents for Hospitalised Paediatric Patients. Paediatric Drugs 3:10, pages 733-761.
Crossref
Crossref
ARIS GIANNOPOULOS, GEORGE KORATZANIS, EVANGELOS J. GIAMARELLOS-BOURBOULIS, CHARALAMPOS PANOU, IOANNIS ADAMAKIS & HELEN GIAMARELLOU. (2001) PHARMACOKINETICS OF CLARITHROMYCIN IN THE PROSTATE: IMPLICATIONS FOR THE TREATMENT OF CHRONIC ABACTERIAL PROSTATITIS. The Journal of Urology 165:1, pages 97-99.
Crossref
Crossref